Use of point-of-care blood ketone testing to diagnose and monitor patients with diabetic ketoacidosis

Annals of Clinical Biochemistry

Volumn 52, Issue 3, 2015, Pages 413-414

  Armer, Jane ^a   Hunt, Natalie ^a  

^a ROYAL PRESTON HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BETAHYDROXYBUTYRATE; BUTYRIC ACID DERIVATIVE; KETONE; UNCLASSIFIED DRUG;

CAPILLARY BLOOD; DIABETIC KETOACIDOSIS; DIAGNOSTIC PROCEDURE; EDITORIAL; HUMAN; LABORATORY DIAGNOSIS; PATIENT MONITORING; POINT OF CARE TESTING; PRACTICE GUIDELINE; PRIORITY JOURNAL; BLOOD; POINT OF CARE SYSTEM;

DIABETIC KETOACIDOSIS; HUMANS; KETONES; POINT-OF-CARE SYSTEMS;

EID: 84930437511     PISSN: 00045632     EISSN: 17581001     Source Type: Journal    
DOI: 10.1177/0004563214564226     Document Type: Editorial

References (4)

1. Dhatariya K.The use of point-of-care blood ketone monitors in the management of diabetic ketoacidosis in adults.Ann Clin Biochem. 2014;51:525-527
2. Dhatariya K, Savage M, Kelly T, et al. Joint British Diabetes Societies Inpatient Care Group. The management of diabetic ketoacidosis in adults. 2nd ed., http://www.diabetologists-abcd.org.uk/JBDS/JBDS_IP_DKA_Adults_Revised.pdf (2013, accessed 1 September 2014).
3. Janssen MJ,Hendrickx BH,Habets-van der Poel CD, et al.Accuracy of the precision point of care ketone test examined by liquid chromatography tandem mass spectrometry (LC-MS/MS) in the same fingerstick sample.Clin Chem Lab Med. 2010;48:1781-1784
4. Armer J,Hunt N,Kaushal K, et al.Limitations to using point of care blood ketone testing to monitor treatment of diabetic ketoacidosis.Pract Diabet. 2013;30:380-382